As the PharmApps site declares, it’s good that we have more and more pharma mobile apps, but it’s becoming increasingly hard to track them and find what we need. So PharmApps aimed at creating a database of these by using proper tags and categories.
We know that in this digital age, the best feedback happens when a broad group of individuals has the ability to upload and comment on content being shared for all to use and digest. We’ve built a resource, or wiki, that, by design, will grow through the input and insight of people interested in the healthcare marketplace, mobile technologies, and apps. The PharmApps wiki aggregates pharma/healthcare apps and gives users the ability to add comments, write reviews, rate apps, and share and upload new apps. The apps are categorized by branded, unbranded, audience, and operating system so users can easily sort through this growing resource. The site will continue to evolve, addressing ongoing feedback, new developments, and our collective learning along the way.
“What everybody was looking for was never going to happen. If you’re waiting for divine guidance, you’re still waiting,” Peter Pitts, president of the Center for Medicine in the Public Interest, told Ad Age. “I doubt there is ever going to be definitive rules for social media-marketing like there are for TV and print. And there’s a reason for that. FDA has made it very clear they were not going to make platform-specific guidelines, like how to use Facebook, how to use Twitter, because social media evolves every day.”
I’m pretty sure it does not do what it should do and help pharma use social media properly. Two fellow bloggers tried to interpret this paper (one and two). As Dose of Digital said:
It’s been a long wait, but the FDA finally delivered. They’ve come through with at least some direction for how pharma companies can properly use social media. It’s not a complete answer to every issue, but it is a good start. I’ve reviewed the full contents of the guidance that the FDA released on December 30, 2011 and found it, not surprisingly, a bit hard to follow at times. The full title of the guidance they released is: “Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices.” Catchy.
Thank you for your email of 16 December 2011 regarding guidelines about using social media.
Please note that the European Medicines Agency (EMA) is a European scientific body responsible for the evaluation of medicines for authorisation purposes within the European Union and the supervision of their safety thereafter. Providing guidance to healthcare professionals and the pharmaceutical industry on using social media is not within the Agency’s remit.
You may find it useful to know that the European Commission adopted on 11 October 2011 two revised proposals clarifying the information that industry can supply to the public on prescription-only medicines. For more information please refer to the following webPage:
I replied to them saying that while the FDA is working on such a guidance, are they sure they are not doing something similar? They replied again:
Thank you for your follow-up email of 3 January 2012 regarding guidelines about using social media.
We can confirm that the European Medicines Agency (EMA) is not developing any guidance for healthcare professionals and the pharmaceutical industry on using social media.
That’s it, my friends. The FDA came out with something but we expected much more; and the EMA is not even planning to deal with social media.
Last year, I published a list of my predictions for 2011 in the areas of healthcare, innovation and technology. Now after a year, I checked these items and actually many of them proved to be right (year of tablets, Prezi.com skyrocketing, Siri leading the way for voice controlled apps, etc.), but now it’s time to come up with the predictions for 2012. Here are my 12 predictions, please feel free to add yours in the comment section.
1) Digital only class in social media for medical professionals and e-patients. Well, that’s quite an easy prediction, as I will launch the global form of my social media in medicine university course this February.
2) Social media policy everywhere. Now that we have an open access social media guide for and about pharma; it’s time for the FDA to come up with their own detailed instructions; also universities, healthcare institutions and medical practices, everyone must have its own as almost everyone is using social media intensively.
3) Augmented reality in radiology. Augmented reality has been a major issue for some time, but seeing the video below made it clear for me, this is where we are going to head in 2012. Doctors can see through patients.
4) Health-fitness gadgets will rock 2012. Myself, I’ve been using Striiv as a fitness motivation tool which also logs my data and visualizes my exercises making it easier for me to make plans and see how I’m doing. Other examples include Jawbone, but you can find even more if you follow the Quantified Self project.
5) Innovations in screen technologies. The form, material and functions of the screens we know now will change dramatically in 2012. Imagine paper screen, holographic screens or flexible screens on your wrist.
6) Internet TV and the operating room. The news sites are full of Apple TV and Google TV, so it’s obvious really innovative internet TVs will be launched in 2012 which brings up the idea of watching operations live on your TV at home. Just check OR-live.com.
7) Pharma will be using social media more intensively. I’m not saying all the pharma companies will have properly designed and managed social media presence, but many brands will use social media more intensively as we should be over now the so-called learing phase and they are getting braver by time.
8) More and more tablet-specific apps. I know the number of medicine/health-related mobile apps is growing rapidly, but now it’s time to turn to tablet-specific clinical apps that could be used in radiology, clinical trials or just for grand rounds.
9) Tablets in healthcare institutions. Whenever I talked to professors and colleagues about how I use my tablet in medicine and healthcare, in a few weeks, many of them had their own tablets and started using those apps. This is contagious. In 2012, a lot of hospitals, clinics and departments will hand out iPad or Galaxy Tabs to their employees in order to facilitate teamwork and make the work processes more efficient.
10) Wikipedia will have more medical featured articles, less medical errors. We recently published a paper describing how Wikipedia can be used for global public health promotion. After years of focus on creating new medical entries in Wikipedia, now we the editors focus on including proper references into medical articles. It is going to lead to a huge improvement in quality.
11) More health bloggers turn to microblogging due to lack of time. Although I believe my blog is still my major platform online even if Twitter is the fastest channel and Facebook is the most interactive. But I understand those health bloggers who leave their blogs and turn to Posterious, Tumblr or Twitter exclusively. It takes less time to post a message or entry therefore they will use these with a bigger chance.
12) Google+ health pages on the rise. I like Google+ and I think it could be used in medical communication successfully. As Google+ has only been letting companies or institutions have G+ pages, we are going to see a rise in their number soon. Even Ed Bennett who maintains a list of hospital social media accounts will include these as well.
Let’s finish my list with a great presentation about the trends in healthcare for 2012.
2011 was a very intense and exciting year regarding the developments and new insights of the relationship between medicine/healthcare and social media. Here are my favourite stories from 2011 selected and featured month by month.
A certain pharmaceutical company contacted me and asked how they can edit Wikipedia entries focusing on their own products. They wish to make corrections as those entries contained misinformation.
This is a tricky issue and while the open access pharma social media guide features a page about Wikipedia, I wanted to ask the community of editors what they think about it.
Please feel free to download it, share it with your colleagues and join us to create an even more sophisticated second version which we can submit to the FDA. Give us feedback on Twitter through #pharmaSMguide!
The original Google Docs document contains more details, negative and positive social media-related pharma case studies as well.
Our latest report, iPad and Smartphone: Pharma and the Super Mobile Revolution examines the rapid changes in mobile and tablet technology, including the trend by HCPs and the industry to use multiple devices to positively impact work flow and business operations. The report tracks how the industry is addressing training, security, consumerization of IT within organizations and advances such as HTML5-Flash and apps.
As a bonus, we’re also offering The Impact of iPads on Pharma: a Primer, which offers a complete examination of what the industry has learned about tablets and how the post-PC tablet is changing internal productivity, growth and sales.